Market Tracker

10/20 5:16pm ET

Emergent BioSolutions Inc (NYSE:EBS)

40.58
Delayed Data
As of Oct 20
 +0.28 / +0.69%
Today’s Change
24.47
Today|||52-Week Range
41.46
+23.57%
Year-to-Date

Today’s Trading

Previous close40.30
Today’s open40.62
Day’s range40.34 - 40.95
Volume319,783
Average volume (3 months)282,955
Market cap$1.7B
Dividend yield--
Data as of 4:02pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-19.86%
Earnings growth (this year)+0.49%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-6.50%
P/E ratio27.8
Price/Sales3.31
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...+0.40+1.21%
LXRXLexicon Pharmaceutic...-0.18-1.59%
INVAInnoviva Inc-0.27-1.91%
MYOKMyoKardia Inc-0.90-2.38%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 3, 2017
EPS forecast (this quarter)$0.34
Annual revenue (last year)$488.8M
Annual profit (last year)$51.8M
Net profit margin12.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
Executive VP-
Business Operations
Adam R. Havey
Corporate headquarters
Gaithersburg, Maryland

Forecasts